SUN 44

Drug Profile

SUN 44

Alternative Names: Gabapentin prodrug - Sun Pharmaceutical Industries; SUN-44

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator Sun Pharmaceutical Industries
  • Class Amines; Aminobutyric acids; Analgesics; Antiepileptic drugs; Antimanics; Antiparkinsonians; Anxiolytics; Cyclohexanecarboxylic acids; Small molecules
  • Mechanism of Action GABA receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported CNS disorders; Seizures

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in CNS-disorders in India (PO)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Seizures in India (PO)
  • 08 Oct 2010 Sun Pharma Advanced Research Company files an IND application with the Drug Controller General in India for CNS disorders and Seizures
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top